about
Is Wilms tumor a candidate neoplasia for treatment with WNT/β-catenin pathway modulators?--A report from the renal tumors biology-driven drug development workshopWilms' tumor: biology, diagnosis and treatmentA genome-wide association study identifies susceptibility loci for Wilms tumorInsights into the experiences of patients with cancer in London: framework analysis of free-text data from the National Cancer Patient Experience Survey 2012/2013 from the two London Integrated Cancer Systems.Incidence of and survival from Wilms' tumour in adults in Europe: data from the EUROCARE study.MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas.Treatment and outcome of patients with relapsed clear cell sarcoma of the kidney: a combined SIOP and AIEOP studyDICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome.Congenital mesoblastic nephroma 50 years after its recognition: A narrative review.Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene.Drug discovery in paediatric oncology: roadblocks to progress.Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practiceSubtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.Treatment of relapsed Wilms tumors: lessons learned.Mesoblastic nephroma: a report of the United Kingdom Children's Cancer and Leukaemia Group (CCLG).European Survey on Standards of Care in paediatric oncology centres.Role of CD56 in Normal Kidney Development and Wilms Tumorigenesis.Gain of 1q is a marker of poor prognosis in Wilms' tumors.Treatment and outcome of Wilms' tumour patients: an analysis of all cases registered in the UKW3 trial.Dose finding study of oral PSC 833 combined with weekly intravenous etoposide in children with relapsed or refractory solid tumours.Cancer in children and adolescents in Europe: developments over 20 years and future challenges.A prospective study of admissions for febrile neutropenia in secondary paediatric units in South East England.Risk factors for local recurrence in Wilms tumour and the potential influence of biopsy - the United Kingdom experience.Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor.Incidence and outcomes of patients with late recurrence of Wilms' tumor.Towards reducing inequalities: European Standards of Care for Children with Cancer.Toxicity and outcome of children and adolescents participating in phase I/II trials of novel anticancer drugs: the Royal Marsden experience.Population survival from childhood cancer in Britain during 1978-2005 by eras of entry to clinical trials.Childhood cancer incidence and survival in Japan and England: A population-based study (1993-2010).PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification.Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study Group.Discrete-choice experiment to analyse preferences for centralizing specialist cancer surgery services.Evidence-based data and rare cancers: The need for a new methodological approach in research and investigation.Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.Medulloblastoma, acute myelocytic leukemia and colonic carcinomas in a child with biallelic MSH6 mutations.Somatic TP53 Mutations Are Detectable in Circulating Tumor DNA from Children with Anaplastic Wilms TumorsSeeking consent to tissue banking: a survey of health professionals in childhood cancerEvaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: Results from the SIOP-WT-2001 RegistryActivation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcomaComparative genomic hybridization and BUB1B mutation analyses in childhood cancers associated with mosaic variegated aneuploidy syndrome
P50
Q26829595-CA806CA5-D64B-476F-B6CE-D6B630514F31Q26862181-F7EFEBFA-8AAE-429B-B21E-BE5CD8D24204Q28943448-D44215BD-CD87-4A35-A306-ABDCB0B08833Q31008120-181F5C7E-D971-484A-B0B7-ABDE7EF0A2ACQ31051842-DCE41A70-178E-4032-9729-9FDC6E3B3EDBQ33906031-D9F75EFF-85C6-4FE1-8B33-3D81CE31BAB8Q33918116-0FA47A35-ECCF-49D8-A526-997E4DAE091BQ34160764-F20492E2-EE30-4EE5-8C26-931AFD45F3E3Q34550059-B34DC0A1-E778-46BD-823A-60C5725A9C60Q35015167-BC13002C-8C86-4DB5-8028-E5A007200E7BQ36262295-C5E6448F-4BDC-415C-A2D4-0A89B106C6F0Q36542374-197DF914-E539-4B30-946A-B8889B476D75Q37437735-A8024289-FC7E-4CB3-AF40-66A62BF08897Q37642795-1A6F37AE-0C1D-467A-922F-520764537409Q37849256-420345C6-0672-4EB7-9E7C-FD84C0FA9504Q38380888-E3A6B0CF-B714-4BF3-8E48-63759370F14BQ39034075-DD4D4EA8-68B4-4EED-B990-83D1A3D2CC44Q39349862-59D77FE7-0558-4A7D-8B3F-68F4588DB275Q39641235-500F966A-8233-4C4D-B957-462452A0EB4DQ40180656-CDED1024-200F-4C98-81DA-98168B05C459Q40296108-D23A8457-03E1-49FE-BC15-9FCCFB8A264FQ40466337-D4BCFE0A-4F63-4336-95F1-8F57E0A05C8AQ41737239-9D68511F-D22A-4ED3-8B70-65CC20716A1FQ43740895-31E6FE47-17F1-452C-90EE-03AC70FB1A74Q43785491-1238832C-A272-44C4-9764-73051391C05CQ45006243-9B72EA7D-6AFC-4494-8FD1-113EABB24079Q46038201-C6493869-8FD9-44EC-BC36-9F2D7CAAC693Q47368648-7C5031BC-F9E0-4AA6-B2B7-38CCABB9A980Q47409538-07410D38-78E7-4451-90AE-E745002E36C9Q47975012-4143B1B7-B0AD-405C-A60E-5508E6EA67EBQ48114539-A251A1D6-0F18-414A-ABB9-3459DE7945E0Q51411752-B2A370C0-3472-411F-A345-C5926F2B456BQ52662124-768D683E-B952-4C21-A396-F5A134745664Q54434638-5DEE25CE-4D98-46F4-AFA4-587FEA4E72E5Q55468550-8DDC1960-6E1B-4A90-A8FA-445DCCCE845AQ56761473-424809E6-58A1-4913-B27E-2A637F81E13DQ56781837-619BC6AF-4989-464F-BF10-1F1A3AC8F7E0Q57173398-36CBF7F3-0348-4C6E-B46B-DA8971DD68F5Q57243407-FE24756A-9777-4CEE-91AA-9C7817DB4636Q57272211-6636A7EA-8F0D-46D1-B44A-F4EE3F47FF2C
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kathryn Pritchard-Jones
@ast
Kathryn Pritchard-Jones
@en
Kathryn Pritchard-Jones
@es
Kathryn Pritchard-Jones
@nl
type
label
Kathryn Pritchard-Jones
@ast
Kathryn Pritchard-Jones
@en
Kathryn Pritchard-Jones
@es
Kathryn Pritchard-Jones
@nl
prefLabel
Kathryn Pritchard-Jones
@ast
Kathryn Pritchard-Jones
@en
Kathryn Pritchard-Jones
@es
Kathryn Pritchard-Jones
@nl
P1053
F-4286-2014
P106
P21
P31
P496
0000-0002-2384-9475